Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 10, 2018

View Archived Issues

Glycosylation of allergens increases immune tolerance following immunization

Finding improves stem cell safety

GABA impairment not down to lack of receptors in ASD

Antigen loss, CAR gain can cause resistance to CAR T therapy

Thalidomide analogue DAID safely and effectively reduces ocular neovascularization in rats

Autologous fecal microbiota transplant restores intestinal microbiota after antibiotic treatment

Olfactory ensheathing cells can deliver therapeutic transgenes to gliomas through the nasal pathway

Merck & Co. presents phase I data for RSV MAb MK-1654

Nymox reports 78-month results from phase IIb prostate cancer study of fexapotide triflutate

M72/AS01 shows efficacy in reducing tuberculosis cases in previously infected HIV-negative adults

First patient enrolled in REIMAGINE phase IIa study of vafidemstat

AgeneBio obtains grants to support phase III study of AGB-101

Cancer drugs may be repurposed for inflammation

Forskolin-induced swelling of intestinal organoids classifies cystic fibrosis disease severity

Acceleron presents preliminary phase II data for ACE-083 in patients with CMT

First-in-human data presented for branaplam in SMA type 1

Neurocrine Biosciences and Jnana collaborate to treat CNS disorders

Newly developed IgA nephropathy murine model shows autoimmune character

Wave Life Sciences to design products for rare inherited eye diseases

Biohaven licenses therapeutic antibody from University of Connecticut

Advanced Proteome Therapeutics reports preclinical finding on antibody-amanitin conjugate

Lixte submits IND for phase Ib/II trial of LB-100 in MDS

Japanese JOINUS research program opens second public recruitment offering

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...